activity
20202022
most citedNovel Radiomic Measurements of Tumor- Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers

41 citations · 56 across the 5 of their papers we have counts for

collaborators

5 papers

q-bio.QM2022★ 41 cited

Novel Radiomic Measurements of Tumor- Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers

Nathaniel Braman, Prateek Prasanna, Kaustav Bera +14

Purpose: Tumor-associated vasculature differs from healthy blood vessels by its chaotic architecture and twistedness, which promotes treatment resistance. Measurable differences in…

eess.IV2021

Radiomic Deformation and Textural Heterogeneity (R-DepTH) Descriptor to characterize Tumor Field Effect: Application to Survival Prediction in Glioblastoma

Marwa Ismail, Prateek Prasanna, Kaustav Bera +10

The concept of tumor field effect implies that cancer is a systemic disease with its impact way beyond the visible tumor confines. For instance, in Glioblastoma (GBM), an aggressiv…

q-bio.QM2020

Spatial-And-Context aware (SpACe) "virtual biopsy" radiogenomic maps to target tumor mutational status on structural MRI

Marwa Ismail, Ramon Correa, Kaustav Bera +8

With growing emphasis on personalized cancer-therapies,radiogenomics has shown promise in identifying target tumor mutational status on routine imaging (i.e. MRI) scans. These appr…

q-bio.QM2020

Can tumor location on pre-treatment MRI predict likelihood of pseudo-progression versus tumor recurrence in Glioblastoma? A feasibility study

Marwa Ismail, Virginia Hill, Volodymyr Statsevych +9

A significant challenge in Glioblastoma (GBM) management is identifying pseudo-progression (PsP), a benign radiation-induced effect, from tumor recurrence, on routine imaging follo…

q-bio.QM2020★ 15 cited

Deep learning-based prediction of response to HER2-targeted neoadjuvant chemotherapy from pre-treatment dynamic breast MRI: A multi-institutional validation study

Nathaniel Braman, Mohammed El Adoui, Manasa Vulchi +10

Predicting response to neoadjuvant therapy is a vexing challenge in breast cancer. In this study, we evaluate the ability of deep learning to predict response to HER2-targeted neo-…